ADHD Flashcards

1
Q

Which stimulants are used in ADHD

A

Dexamfetamine / lisdexamfetamine
Methylphenidate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dexamfetamine / lisdexamfetamine mechanism

A

Increases synaptic levels of dopamine and noradrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dexamfetamine / lisdexamfetamine contraindications

A

Significant cardiovascular disorders
Cerebrovascular disorders
Use of MAO inhibitors
Hx of drug abuse
Hyperthyroidism
Glaucoma
Porphyria
Gilles de la Tourette syndrome or similar dystonias
Pregnancy and lactation
Psychosis or bipolar I (if not well controlled)
Anorexia
Significant suicidal ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dexamfetamine / lisdexamfetamine common s/e

A
  • decreased appetite
  • reduced weight gain and weight loss during prolonged use in children
  • insomnia
  • nervousness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dexamfetamine / lisdexamfetamine interactions

A

Minimal effect on CYP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Methylphenidate mechanism

A

Increases synaptic levels of dopamine and noradrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Methylphenidate contraindications

A

Significant cardiovascular disorders
Cerebrovascular disorders
Glaucoma
Phaechromocytoma
Use of MAO inhibitors
Psychosis or bipolar I (if not well controlled)
Anorexia
Significant suicidal ideation
Hyperthyroidism or thyrotoxicosi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Methylphenidate common SE

A
  • decreased appetite
  • insomnia
  • nervousness
  • headache
  • nausea
  • dry mouth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

t/f Methylphenidate has a significant effect on CYP

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non stimulant ADHD medications

A

Atomoxetine
Guanfacine
Clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Atomoxetine mechanism

A

Increasing NA levels in the synaptic cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Atomoxetine contraindications

A

Use of MAO inhibitors
Glaucoma
Pheochromocytoma
Significant cardiovascular disorders
Cerebrovascular disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Atomoxetine common SE

A
  • appetite decreased
  • headache
  • somnolence
  • abdominal pain (includes epigastric discomfort)
  • vomiting
  • nausea
  • blood pressure increased
  • heart rate increased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atomoxetine is metabolised by

A

CYP2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Guanfacine mechanism

A

Selective agonist of α2A-adrenergic receptors. Binds to postsynaptic α2A-adrenergic receptors, mimicking NA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Guanfacine contrainidcations

A

No specific contraindications other than hypersensitivity to the drug

17
Q

Guanfacine common SE

A

somnolence (40%)
- headache (27%)
- fatigue (18%)
- abdominal pain (12%)

18
Q

Guanfacine metabolism and interactions

A

Metabolised by CYP3A4/5
Can increase levels of valproic acid

19
Q

Clonidine mechanism

A

Agonist of α2-adrenergic receptors, mimic NA

20
Q

Clonidine contraindications

A

Severe bradyarrhythmia resulting from either sick-sinus syndrome or AV block of 2nd or 3rd degree

21
Q

Clonidine SE

A
  • dizziness
  • sedation
  • orthostatic hypotension
  • dry mouth
22
Q

Clonidine metabolism

A

No significant effect on CYP
Much of the drug excreted unchanged in urine

23
Q

Mechanism of Lisdexamfetamine

A

Prodrug, absorbed by GI tract, converted to dexamfetamine which inhibits the reuptake of NA and DA. Converted by enzymes in red blood cells into dexamfetamine and L-lysine (amino acid). The activation of the prodrug results in longer action and a reduced abuse potential

24
Q

Mechanism of Dexamfetamine

A

Inhibiting DA (dopamine) and NA (noradrenaline) reuptake

25
Q

Mechanism of Methylphenidate

A

Inhibiting DA and NA reuptake